The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma
Official Title: Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma - A Randomised Phase III Trial
Study ID: NCT01503827
Brief Summary: People with brain metastases from melanoma are offered different treatment options after local treatment of their brain metastases via surgery or stereotactic irradiation. Depending on the treating institution and the clinician involved a patient may or may not be offered whole brain radiotherapy (WBRT) after their brain metastases are excised or treated with stereotactic irradiation. This trial seeks to determine if WBRT reduces the spread of brain metastases and lengthens the time to recurrence. The trial also examines the effect of WBRT on quality of life and brain functions such as memory, speech and concentration. Participants will be randomised after local treatment of their brain metastases to either WBRT or observation. 220 people will be recruited from sites in Australia, Norway, the UK, the US and other international sites.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
St Vincent's Hospital, Darlinghurst, New South Wales, Australia
Calvary Mater Hospital, Newcastle, New South Wales, Australia
Genesis Cancer Care - Gateshead, Newcastle, New South Wales, Australia
Melanoma Institute Australia / Royal Prince Alfred Hospital, North Sydney, New South Wales, Australia
Nepean Hospital, Penrith, New South Wales, Australia
Westmead Hospital, Westmead, New South Wales, Australia
Darwin Hospital, NT Radiation Oncology, Darwin, Northern Territory, Australia
Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
Radiation Oncology Services - Mater Centre, South Brisbane, Queensland, Australia
Townsville Hospital, Townsville, Queensland, Australia
Genesis Cancer Care - Tugun, Tugun, Queensland, Australia
Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
Royal Adelaide Hospital, Adelaide, South Australia, Australia
Royal Hobart Hospital, Hobart, Tasmania, Australia
Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
Alfred Hospital, Melbourne, Victoria, Australia
Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
The Norwegian Radium Hospital, Oslo, , Norway
Velindre Hospital, Whitchurch, Cardiff, United Kingdom
Mount Vernon Cancer Centre, Northwood, Middlesex, United Kingdom
Churchill Hospital, Headington, Oxford, United Kingdom
St. James University Hospital, Leeds, , United Kingdom
Norfolk & Norwich University Hospital, Norwich, , United Kingdom
Name: Gerald Fogarty, BSc, MBBS
Affiliation: Mater Hospital, St Vincent's Hospital, Melanoma Institue Australia
Role: STUDY_CHAIR